149 related articles for article (PubMed ID: 37648793)
1. New predictive models and indices for screening MAFLD in school-aged overweight/obese children.
Xing Y; Zhang P; Li X; Jin S; Xu M; Jia J; Wang HJ; Li L; Wang H
Eur J Pediatr; 2023 Nov; 182(11):5025-5036. PubMed ID: 37648793
[TBL] [Abstract][Full Text] [Related]
2. Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity.
Oses M; Cadenas-Sanchez C; Medrano M; Galbete A; Miranda-Ferrua E; Ruiz JR; Sánchez-Valverde F; Ortega FB; Cabeza R; Villanueva A; Idoate F; Labayen I
Pediatr Obes; 2022 Sep; 17(9):e12917. PubMed ID: 35394122
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort.
Zeng J; Jin Q; Yang J; Yang RX; Zhang RN; Zhao J; Fan JG
Hepatol Int; 2023 Dec; 17(6):1416-1428. PubMed ID: 37728728
[TBL] [Abstract][Full Text] [Related]
4. Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis.
Abeysekera KWM; Orr JG; Gordon FH; Howe LD; Hamilton-Shield J; Heron J; Hickman M
BMC Gastroenterol; 2022 Jun; 22(1):323. PubMed ID: 35773644
[TBL] [Abstract][Full Text] [Related]
5. Simple proxies of insulin resistance identify obese metabolic dysfunction-associated fatty liver disease subjects with advanced liver disease.
Petralli G; Salvati A; Tricò D; Ricco G; Colombatto P; Brunetto MR; Solini A
Diabetes Metab Res Rev; 2024 Feb; 40(2):e3736. PubMed ID: 37839068
[TBL] [Abstract][Full Text] [Related]
6. Updated upper limits of normal serum alanine aminotrasferase levels for screening metabolic dysfunction-associated fatty liver disease in obese children.
Lin YC; Chang PF; Ni YH
J Formos Med Assoc; 2022 Dec; 121(12):2548-2555. PubMed ID: 35738972
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and associated factors of metabolic-associated fatty liver disease in overweight Finnish children and adolescents.
Riekki H; Aitokari L; Kivelä L; Lahti S; Hiltunen P; Vuorela N; Huhtala H; Lakka TA; Kurppa K
Front Endocrinol (Lausanne); 2023; 14():1090344. PubMed ID: 37409224
[TBL] [Abstract][Full Text] [Related]
8. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
Xue Y; Xu J; Li M; Gao Y
Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
[TBL] [Abstract][Full Text] [Related]
9. Maternal gestational hypertension, smoking and pre-eclampsia are associated with metabolic dysfunction-associated fatty liver disease in overweight offspring.
de Ruyter H; Aitokari L; Lahti S; Riekki H; Huhtala H; Lakka T; Laivuori H; Kurppa K
Acta Obstet Gynecol Scand; 2024 Jun; 103(6):1183-1191. PubMed ID: 38433535
[TBL] [Abstract][Full Text] [Related]
10. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults.
Kühn T; Nonnenmacher T; Sookthai D; Schübel R; Quintana Pacheco DA; von Stackelberg O; Graf ME; Johnson T; Schlett CL; Kirsten R; Ulrich CM; Kaaks R; Kauczor HU; Nattenmüller J
BMC Gastroenterol; 2018 Jul; 18(1):113. PubMed ID: 30005625
[TBL] [Abstract][Full Text] [Related]
11. Amino acid profile in overweight and obese prepubertal children - can simple biochemical tests help in the early prevention of associated comorbidities?
Bugajska J; Berska J; Wójcik M; Sztefko K
Front Endocrinol (Lausanne); 2023; 14():1274011. PubMed ID: 37964971
[TBL] [Abstract][Full Text] [Related]
12. Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.
Chen J; Mao X; Deng M; Luo G
Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):394-401. PubMed ID: 36695773
[TBL] [Abstract][Full Text] [Related]
13. [Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease].
Hou MM; Yuan XW; Wang YQ; Zhang Y; Zhang SY; Yu SH; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):290-296. PubMed ID: 35462485
[No Abstract] [Full Text] [Related]
14. Waist to height ratio: a simple screening tool for nonalcoholic fatty liver disease in obese children.
Özhan B; Ersoy B; Özkol M; Kiremitci S; Ergin A
Turk J Pediatr; 2016; 58(5):518-523. PubMed ID: 28621093
[TBL] [Abstract][Full Text] [Related]
15. Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease.
Lee CH; Lui DT; Li RH; Yuen MM; Fong CH; Leung AP; Chu JC; Mak LL; Lam TH; Woo J; Woo YC; Xu A; Tse HF; Tan KC; Cheung BM; Yuen MF; Lam KS
Front Endocrinol (Lausanne); 2022; 13():1056562. PubMed ID: 36686469
[TBL] [Abstract][Full Text] [Related]
16. What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children?
Lee JH; Jeong SJ
World J Pediatr; 2017 Jun; 13(3):248-254. PubMed ID: 28101773
[TBL] [Abstract][Full Text] [Related]
17. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
Otsubo N; Fukuda T; Cho G; Ishibashi F; Yamada T; Monzen K
Intern Med; 2023 Aug; 62(16):2307-2319. PubMed ID: 36517035
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
[TBL] [Abstract][Full Text] [Related]
19. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.
Cai J; Lin C; Lai S; Liu Y; Liang M; Qin Y; Liang X; Tan A; Gao Y; Lu Z; Wu C; Huang S; Yang X; Zhang H; Kuang J; Mo Z
Lipids Health Dis; 2021 Oct; 20(1):145. PubMed ID: 34706716
[TBL] [Abstract][Full Text] [Related]
20. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors.
Thiagarajan S; Shrinuvasan S; Arun Babu T
Indian J Gastroenterol; 2022 Feb; 41(1):63-68. PubMed ID: 35064452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
